So, in this study, we described a straightforward microfluidic device for the investigation of the response of myofibroblasts induced by lung cancer cells to anticancer drug VP-16 and the chemoresistant mechanism associated with GRP78 up-regulation. Here, HSPA5 is linked to lung cancer.